N-Methyldopamine hydrochloride, a modified version of dopamine (DA) that maintains agonist activity at the DA1 receptor, serves as an adrenaline precursor in the adrenal medulla. It retains the capability for universal surface coating and undergoes secondary reactions via surface catechols. This compound is utilized in heart failure research [1] [2] [3].

N-Methyldopamine hydrochloride has highly improved surface coating properties and exhibits an accelerated coating rate. N-Methyldopamine hydrochloride coating makes solid surface cell adhesion possible, and post-functionalization of the coating is also possible [1].